Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiamine for Oxygen Consumption After Cardiac Arrest
NCT02974257Phase 2Terminated
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- May 2017
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cardiac arrest (SCA) and lactic acidosis comparing Thiamine with Placebo (2 arms). Primary endpoint: Lactate at 2 days. Started May 2017; status: terminated.
02
Drugs
thiamine
03
Conditions
cardiac arrest (SCA)lactic acidosis
Beyond the preview
Go deeper on NCT02974257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02974257.